Figure S6 from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1

Figure S6 from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1

<p>CADM1-mediated proliferation, migration and invasion in EMX2 overexpressing RCC cells</p>

Сохранить в:

Библиографические подробности
Главный автор:	Zhibin Fu (21644135) (author)
Другие авторы:	Wenqi Chen (21644138) (author), Di Gu (21644141) (author), Juan Li (21644144) (author), Kai Dong (21644147) (author), Yuying Lan (21644150) (author), Tao Liu (21644153) (author), Bianhong Zhang (21644156) (author), Lei Li (21644159) (author), Ethan Lee (21644162) (author), Chenghua Yang (21644165) (author), Tao P. Zhong (21644168) (author), Linhui Wang (21644171) (author)
Опубликовано:	2025
Предметы:	Cancer Cancer Biology Tumor Biology Molecular and Cellular Biology Cell Death And Senescence Transcriptional control of apoptosis Genitourinary Cancers Renal cancer Oncogenes & Tumor Suppressors Tumor suppressor genes Progression, Invasion & Metastasis
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!

Схожие документы

Figure S2 from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1
по: Zhibin Fu (21644135)
Опубликовано: (2025)

Figure S3 from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1
по: Zhibin Fu (21644135)
Опубликовано: (2025)

Figure S4 from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1
по: Zhibin Fu (21644135)
Опубликовано: (2025)

Figure S5 from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1
по: Zhibin Fu (21644135)
Опубликовано: (2025)

Figure S7 from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1
по: Zhibin Fu (21644135)
Опубликовано: (2025)

Figure S8 from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1
по: Zhibin Fu (21644135)
Опубликовано: (2025)

Figure S1C from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1
по: Zhibin Fu (21644135)
Опубликовано: (2025)

Figure S1A-B from Empty Spiracles Homeobox 2 Transcription Factor Functions as a Tumor Suppressor in Renal Cell Carcinoma by Targeting CADM1
по: Zhibin Fu (21644135)
Опубликовано: (2025)

Table S1 from Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21–5p/TGFBR2/P38/EGR1 Axis
по: Chenguang Wang (15099311)
Опубликовано: (2025)

Table S2 from Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21–5p/TGFBR2/P38/EGR1 Axis
по: Chenguang Wang (15099311)
Опубликовано: (2025)

Table S3 from Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21–5p/TGFBR2/P38/EGR1 Axis
по: Chenguang Wang (15099311)
Опубликовано: (2025)

Table S4 from Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21–5p/TGFBR2/P38/EGR1 Axis
по: Chenguang Wang (15099311)
Опубликовано: (2025)

Table S5 from Hypertension Promotes the Proliferation and Migration of ccRCC Cells by Downregulation of TIMP3 in Tumor Endothelial Cells through the miR-21–5p/TGFBR2/P38/EGR1 Axis
по: Chenguang Wang (15099311)
Опубликовано: (2025)

Supplementary Data 1 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
по: Joshua H. Choe (15306085)
Опубликовано: (2025)

Supplementary Data 2 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
по: Joshua H. Choe (15306085)
Опубликовано: (2025)

Supplementary Data 3 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
по: Joshua H. Choe (15306085)
Опубликовано: (2025)

Supplementary Data 4 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
по: Joshua H. Choe (15306085)
Опубликовано: (2025)

Supplementary Data 5 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
по: Joshua H. Choe (15306085)
Опубликовано: (2025)

Supplementary Data 6 from Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death
по: Joshua H. Choe (15306085)
Опубликовано: (2025)

Figure S1 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
по: Yuanqing Ma (15052437)
Опубликовано: (2025)

Figure S2 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
по: Yuanqing Ma (15052437)
Опубликовано: (2025)

Figure S3 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
по: Yuanqing Ma (15052437)
Опубликовано: (2025)

Figure S4 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
по: Yuanqing Ma (15052437)
Опубликовано: (2025)

Figure S5 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
по: Yuanqing Ma (15052437)
Опубликовано: (2025)

Figure S6 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
по: Yuanqing Ma (15052437)
Опубликовано: (2025)

Figure S7 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
по: Yuanqing Ma (15052437)
Опубликовано: (2025)

Figure S8 from HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans
по: Yuanqing Ma (15052437)
Опубликовано: (2025)

Table S1 from Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer
по: Nitin H. Shirole (21652456)
Опубликовано: (2025)

Table S2 from Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer
по: Nitin H. Shirole (21652456)
Опубликовано: (2025)

Table S3 from Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer
по: Nitin H. Shirole (21652456)
Опубликовано: (2025)

Table S4 from Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer
по: Nitin H. Shirole (21652456)
Опубликовано: (2025)

Table S5 from Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer
по: Nitin H. Shirole (21652456)
Опубликовано: (2025)

Table S6 from Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer
по: Nitin H. Shirole (21652456)
Опубликовано: (2025)

Table S7 from Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer
по: Nitin H. Shirole (21652456)
Опубликовано: (2025)

Table S8 from Requirement for Cyclin D1 Underlies Cell-Autonomous HIF2 Dependence in Kidney Cancer
по: Nitin H. Shirole (21652456)
Опубликовано: (2025)

Table S2 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
по: Qiangsheng Hu (15400215)
Опубликовано: (2025)

Table S3 from ASS1-Mediated Reductive Carboxylation of Cytosolic Glutamine Confers Ferroptosis Resistance in Cancer Cells
по: Qiangsheng Hu (15400215)
Опубликовано: (2025)

Figure 1 from HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models
по: Valentí Gómez (15088902)
Опубликовано: (2025)

Figure 2 from HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models
по: Valentí Gómez (15088902)
Опубликовано: (2025)

Figure 3 from HER2 Mediates PSMA/mGluR1-Driven Resistance to the DS-7423 Dual PI3K/mTOR Inhibitor in PTEN Wild-type Prostate Cancer Models
по: Valentí Gómez (15088902)
Опубликовано: (2025)